Protection against ischemia-induced oxidative stress conferred by vagal stimulation in the rat heart: Involvement of the AMPK-PKC pathway

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 14311-14325

  Kong, Shan Shan ^a   Liu, Jin Jun ^a   Yu, Xiao Jiang ^a   Lu, Yi ^a   Zang, Wei Jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Muscarinic acetylcholine receptor; Oxidase stress; Reactive oxygen species; Vagal stimulation

Indexed keywords

3 NITROTYROSINE; ADENYLATE KINASE; CELL PROTEIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; P67PHOX PROTEIN; PROTEIN KINASE C; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; ANIMAL; BLOOD; BLOOD ANALYSIS; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; HEART; HEART INFARCTION; HEART MUSCLE; HEART RATE; HEMODYNAMICS; ISCHEMIA; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; CORONARY CIRCULATION; HEART; HEART RATE; HEMODYNAMICS; ISCHEMIA; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NADP; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION; VAGUS NERVE STIMULATION;

EID: 84870668412     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131114311     Document Type: Article

References (33)

1. Bagatini, M.D.; Martins, C.C.; Battisti, V.; Gasparetto, D.; Da, R.C.; Spanevello, R.M.; Ahmed, M.; Schmatz, R.; Schetinger, M.R.; Morsch, V.M. Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels 2011, 26, 55-63.
2. Vanden, H.T.; Li, C.; Shao, Z.; Schumacker, P.T.; Becker, L.B. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 1997, 29, 2571-2583.
3. Sun, B.; Sun, G.B.; Xiao, J.; Chen, R.C.; Wang, X.; Wu, Y.; Cao, L.; Yang, Z.H.; Sun, X.B. Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J. Cell. Biochem. 2012, 113, 473-485.
4. Murdoch, C.E.; Grieve, D.J.; Cave, A.C.; Looi, Y.H.; Shah, A.M. NADPH oxidase and heart failure. Curr. Opin. Pharmacol. 2006, 6, 148-153.
5. Bedard, K.; Krause, K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007, 87, 245-313.
6. Akki, A.; Zhang, M.; Murdoch, C.; Brewer, A.; Shah, A.M. NADPH oxidase signaling and cardiac myocyte function. J. Mol. Cell. Cardiol. 2009, 47, 15-22.
7. Meischl, C.; Krijnen, P.A.; Sipkens, J.A.; Cillessen, S.A.; Munoz, I.G.; Okroj, M.; Ramska, M.; Muller, A.; Visser, C.A.; Musters, R.J.; et al. Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis. Apoptosis 2006, 11, 913-921.
8. Krijnen, P.A.; Meischl, C.; Hack, C.E.; Meijer, C.J.; Visser, C.A.; Roos, D.; Niessen, H.W. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J. Clin. Pathol. 2003, 56, 194-199.
9. Heymes, C.; Bendall, J.K.; Ratajczak, P.; Cave, A.C.; Samuel, J.L.; Hasenfuss, G.; Shah, A.M. Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 2003, 41, 2164-2171.
10. Byrne, J.A.; Grieve, D.J.; Bendall, J.K.; Li, J.M.; Gove, C.; Lambeth, J.D.; Cave, A.C.; Shah, A.M. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 2003, 93, 802-805.
11. Sroka, K. On the genesis of myocardial ischemia. Z. Kardiol. 2004, 93, 768-783.
12. Jardine, D.L.; Charles, C.J.; Ashton, R.K.; Bennett, S.I.; Whitehead, M.; Frampton, C.M.; Nicholls, M.G. Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J. Physiol. 2005, 565, 325-333.
13. Jankowska, E.A.; Ponikowski, P.; Piepoli, M.F.; Banasiak, W.; Anker, S.D.; Poole-Wilson, P.A. Autonomic imbalance and immune activation in chronic heart failure-Pathophysiological links. Cardiovasc. Res. 2006, 70, 434-445.
14. Kong, S.S.; Liu, J.J.; Hwang, T.C.; Yu, X.J.; Lu, Y.; Zang, W.J. Tumour necrosis factor-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Clin. Exp. Pharmacol. Physiol. 2011, 38, 300-306.
15. Li, M.; Zheng, C.; Sato, T.; Kawada, T.; Sugimachi, M.; Sunagawa, K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004, 109, 120-124.
16. Schwartz, P.J.; de Ferrari, G.M.; Sanzo, A.; Landolina, M.; Rordorf, R.; Raineri, C.; Campana, C.; Revera, M.; Ajmone-Marsan, N.; Tavazzi, L.; et al. Long term vagal stimulation in patients with advanced heart failure: First experience in man. Eur. J. Heart Fail. 2008, 10, 884-891.
17. Ando, M.; Katare, R.G.; Kakinuma, Y.; Zhang, D.; Yamasaki, F.; Muramoto, K.; Sato, T. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 2005, 112, 164-170.
18. Brack, K.E.; Patel, V.H.; Coote, J.H.; Ng, G.A. Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J. Physiol. 2007, 583, 695-704.
19. Ceolotto, G.; Papparella, I.; Lenzini, L.; Sartori, M.; Mazzoni, M.; Iori, E.; Franco, L.; Gallo, A.; de Kreutzenberg, S.V.; Tiengo, A.; et al. Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin. Free Radic. Biol. Med. 2006, 41, 473-483.
20. Tsai, K.L.; Chen, L.H.; Chiou, S.H.; Chiou, G.Y.; Chen, Y.C.; Chou, H.Y.; Chen, L.K.; Chen, H.Y.; Chiu, T.H.; Tsai, C.S.; et al. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol. Nutr. Food Res. 2011, 55, S227-S240.
21. Siwik, D.A.; Tzortzis, J.D.; Pimental, D.R.; Chang, D.L.; Pagano, P.J.; Singh, K.; Sawyer, D.B.; Colucci, W.S. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ. Res. 1999, 85, 147-153.
22. Ookawara, T.; Imazeki, N.; Matsubara, O.; Kizaki, T.; Oh-Ishi, S.; Nakao, C.; Sato, Y.; Ohno, H. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am. J. Physiol. 1998, 275, C840-C847.
23. Roe, N.D.; Thomas, D.P.; Ren, J. Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes Obes. Metab. 2011, 13, 465-473.
24. Rothwell, S.E.; Richards, A.M.; Pemberton, C.J. Resistin worsens cardiac ischaemia-reperfusion injury. Biochem. Biophys. Res. Commun. 2006, 349, 400-407.
25. Hardie, D.G.; Carling, D. The AMP-activated protein kinase-Fuel gauge of the mammalian cell? Eur. J. Biochem. 1997, 246, 259-273.
26. Bey, E.A.; Xu, B.; Bhattacharjee, A.; Oldfield, C.M.; Zhao, X.; Li, Q.; Subbulakshmi, V.; Feldman, G.M.; Wientjes, F.B.; Cathcart, M.K. Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes. J. Immunol. 2004, 173, 5730-5738.
27. Ceolotto, G.; Gallo, A.; Papparella, I.; Franco, L.; Murphy, E.; Iori, E.; Pagnin, E.; Fadini, G.P.; Albiero, M.; Semplicini, A.; et al. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2627-2633.
28. Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals; National Institutes of Health publication No. 85-23; National Academies Press: Washington, DC, USA, 1996.
29. Krishnamurthy, P.; Rajasingh, J.; Lambers, E.; Qin, G.; Losordo, D.W.; Kishore, R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ. Res. 2009, 104, e9-e18.
30. Yao, Y.Y.; Yin, H.; Shen, B.; Chao, L.; Chao, J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. J. Card Fail. 2007, 13, 588-596.
31. Nakahara, T.; Kawada, T.; Sugimachi, M.; Miyano, H.; Sato, T.; Shishido, T.; Yoshimura, R.; Miyashita, H.; Inagaki, M.; Alexander, J.J.; et al. Accumulation of cAMP augments dynamic vagal control of heart rate. Am. J. Physiol. 1998, 275, H562-H567.
32. Kawada, T.; Yamazaki, T.; Akiyama, T.; Li, M.; Ariumi, H.; Mori, H.; Sunagawa, K.; Sugimachi, M. Vagal stimulation suppresses ischemia-induced myocardial interstitial norepinephrine release. Life Sci. 2006, 78, 882-887.
33. Lee, T.M.; Chen, C.C.; Hsu, Y.J. Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. Free Radic. Biol. Med. 2011, 50, 1461-1470.